Life sciences company signs university vaccine deal

Life sciences company Aptamer Group has signed a licensing agreement with the University of Glasgow for exclusive rights to its synthetic binders to develop swine flu vaccines.

Under the agreement, the university will use Aptamer’s panel of optimer binders as vaccine adjuvants with commercialisation anticipated within the next 12 months.

York-based Aptamer will receive a 10% royalty on all future revenues from any vaccines incorporating the... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...